Advanced Clinical actively supports emerging biotechnology organizations during and ahead of their funding rounds. A preliminary pricing is an initial estimate of budget and timelines based on high level trial objectives, carrying a level of uncertainty for when a full protocol and/or trial design is not available. Once Advanced Clinical has qualified this information and identified that it therapeutically aligns with our expertise, it will be considered non-binding, for discussion purposes only, and will not serve as the basis of a binding agreement. Please fill out the form below and a member of our team will be in touch.

*Indicates required field